{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-007552","form_type":"8-K","ticker":"CNSP","cik":"0001729427","company_name":"CNS Pharmaceuticals, Inc.","filed_at":"2026-10-02T12:00:14+00:00","discovered_at":"2026-10-02T12:05:00.456653+00:00","generated_at":"2026-10-12T14:31:27.912968+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"CNS Pharmaceuticals holders approve 650,000-share Equity Plan increase; six directors elected at annual meeting","bullets":["Stockholders approved amending the 2020 Equity Plan to add 650,000 shares, raising total shares authorized for issuance to 765,061 from 115,061; vote was 96,953 for, 8,128 against, 35 abstain.","Rami Levin, Amy Mahery, Faith Charles, Bettina Cockroft, Michal Fisher and Jeffrey Keyes elected directors to serve until the 2027 annual meeting; each received between 100,524 and 102,460 votes for.","MaloneBailey, LLP ratified as independent registered public accounting firm for the year ending December 31, 2026: 637,228 for, 30,874 against, 89 abstain.","Advisory say-on-pay resolution approved with 98,103 for and 6,682 against; adjournment-of-meeting proposal authorized 622,421 for vs 45,635 against.","Annual meeting held September 30, 2026 with 668,188 shares (45.72%) present by proxy or in person, constituting a quorum; 1,461,449 shares outstanding at the August 10, 2026 record date."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-007552","json":"https://secwatch.observer/filing/0001683168-26-007552.json","markdown":"https://secwatch.observer/filing/0001683168-26-007552.md","text":"https://secwatch.observer/filing/0001683168-26-007552.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729427/000168316826007552/0001683168-26-007552-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729427/000168316826007552/cns_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T14:31:27.912968+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}